Coronacast | The mysterious company behind a misleading coronavirus drug study
Coronacast | The mysterious company behind a misleading coronavirus drug study
When the World Health Organisation saw data from a study into a possible coronavirus drug treatment, it immediately halted trials for safety reasons.
The data implied that use of the drug hydroxychloroquine didn't help COVID-19 patients at best, and was even possibly harmful.
But it turns out that the data were suspect, misleading and based on some pretty weird assumptions.
Today, the story of a mysterious company that changed coronavirus treatment policies, and has called into question how medical studies are published.
When the World Health Organisation saw data from a study into a possible coronavirus drug treatment, it immediately halted trials for safety reasons.
The data implied that use of the drug hydroxychloroquine didn't help COVID-19 patients at best, and was even possibly harmful.
But it turns out that the data were suspect, misleading and based on some pretty weird assumptions.
Today, the story of a mysterious company that changed coronavirus treatment policies, and has called into question how medical studies are published.